Copyright Reports & Markets. All rights reserved.

Global Dermatology OTC Medications Market Insights and Forecast to 2027

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Dermatology OTC Medications Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Dermatology OTC Medications Market Size Growth Rate by Type
    • 1.4.2 External Use
    • 1.4.3 Oral
  • 1.3 Market by Application
    • 1.3.1 Global Dermatology OTC Medications Market Size Growth Rate by Application
    • 1.3.2 Hospital
    • 1.3.3 Drug Store
    • 1.3.4 Other
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Executive Summary

  • 2.1 Global Dermatology OTC Medications Sales Estimates and Forecasts 2016-2027
  • 2.2 Global Dermatology OTC Medications Revenue Estimates and Forecasts 2016-2027
  • 2.3 Global Dermatology OTC Medications Revenue by Region: 2016 VS 2021 VS 2027
  • 2.4 Global Top Dermatology OTC Medications Regions by Sales
    • 2.4.1 Global Top Dermatology OTC Medications Regions by Sales (2016-2021)
    • 2.4.2 Global Top Dermatology OTC Medications Regions by Sales (2022-2027)
  • 2.5 Global Top Dermatology OTC Medications Regions by Revenue
    • 2.5.1 Global Top Dermatology OTC Medications Regions by Revenue (2016-2021)
    • 2.5.2 Global Top Dermatology OTC Medications Regions by Revenue (2022-2027)
  • 2.6 North America
  • 2.7 Europe
  • 2.8 Asia-Pacific
  • 2.9 Latin America
  • 2.10 Middle East & Africa

3 Competition by Manufacturers

  • 3.1 Global Dermatology OTC Medications Sales by Manufacturers
    • 3.1.1 Global Top Dermatology OTC Medications Manufacturers by Sales (2016-2021)
    • 3.1.2 Global Top Dermatology OTC Medications Manufacturers Market Share by Sales (2016-2021)
    • 3.1.3 Global Top 10 and Top 5 Companies by Dermatology OTC Medications Sales in 2020
  • 3.2 Global Dermatology OTC Medications Revenue by Manufacturers
    • 3.2.1 Global Top Dermatology OTC Medications Manufacturers by Revenue (2016-2021)
    • 3.2.2 Global Top Dermatology OTC Medications Manufacturers Market Share by Revenue (2016-2021)
    • 3.2.3 Global Top 10 and Top 5 Companies by Dermatology OTC Medications Revenue in 2020
  • 3.3 Global Dermatology OTC Medications Sales Price by Manufacturers
  • 3.4 Analysis of Competitive Landscape
    • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Dermatology OTC Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.4.3 Global Dermatology OTC Medications Manufacturers Geographical Distribution
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Dermatology OTC Medications Sales by Type
    • 4.1.1 Global Dermatology OTC Medications Historical Sales by Type (2016-2021)
    • 4.1.2 Global Dermatology OTC Medications Forecasted Sales by Type (2022-2027)
    • 4.1.3 Global Dermatology OTC Medications Sales Market Share by Type (2016-2027)
  • 4.2 Global Dermatology OTC Medications Revenue by Type
    • 4.2.1 Global Dermatology OTC Medications Historical Revenue by Type (2016-2021)
    • 4.2.2 Global Dermatology OTC Medications Forecasted Revenue by Type (2022-2027)
    • 4.2.3 Global Dermatology OTC Medications Revenue Market Share by Type (2016-2027)
  • 4.3 Global Dermatology OTC Medications Price by Type
    • 4.3.1 Global Dermatology OTC Medications Price by Type (2016-2021)
    • 4.3.2 Global Dermatology OTC Medications Price Forecast by Type (2022-2027)

5 Market Size by Application

  • 5.1 Global Dermatology OTC Medications Sales by Application
    • 5.1.1 Global Dermatology OTC Medications Historical Sales by Application (2016-2021)
    • 5.1.2 Global Dermatology OTC Medications Forecasted Sales by Application (2022-2027)
    • 5.1.3 Global Dermatology OTC Medications Sales Market Share by Application (2016-2027)
  • 5.2 Global Dermatology OTC Medications Revenue by Application
    • 5.2.1 Global Dermatology OTC Medications Historical Revenue by Application (2016-2021)
    • 5.2.2 Global Dermatology OTC Medications Forecasted Revenue by Application (2022-2027)
    • 5.2.3 Global Dermatology OTC Medications Revenue Market Share by Application (2016-2027)
  • 5.3 Global Dermatology OTC Medications Price by Application
    • 5.3.1 Global Dermatology OTC Medications Price by Application (2016-2021)
    • 5.3.2 Global Dermatology OTC Medications Price Forecast by Application (2022-2027)

6 North America

  • 6.1 North America Dermatology OTC Medications Market Size by Type
    • 6.1.1 North America Dermatology OTC Medications Sales by Type (2016-2027)
    • 6.1.2 North America Dermatology OTC Medications Revenue by Type (2016-2027)
  • 6.2 North America Dermatology OTC Medications Market Size by Application
    • 6.2.1 North America Dermatology OTC Medications Sales by Application (2016-2027)
    • 6.2.2 North America Dermatology OTC Medications Revenue by Application (2016-2027)
  • 6.3 North America Dermatology OTC Medications Market Size by Country
    • 6.3.1 North America Dermatology OTC Medications Sales by Country (2016-2027)
    • 6.3.2 North America Dermatology OTC Medications Revenue by Country (2016-2027)
    • 6.3.3 U.S.
    • 6.3.4 Canada

7 Europe

  • 7.1 Europe Dermatology OTC Medications Market Size by Type
    • 7.1.1 Europe Dermatology OTC Medications Sales by Type (2017-2027)
    • 7.1.2 Europe Dermatology OTC Medications Revenue by Type (2017-2027)
  • 7.2 Europe Dermatology OTC Medications Market Size by Application
    • 7.2.1 Europe Dermatology OTC Medications Sales by Application (2017-2027)
    • 7.2.2 Europe Dermatology OTC Medications Revenue by Application (2017-2027)
  • 7.3 Europe Dermatology OTC Medications Market Size by Country
    • 7.3.1 Europe Dermatology OTC Medications Sales by Country (2017-2027)
    • 7.3.2 Europe Dermatology OTC Medications Revenue by Country (2017-2027)
    • 7.3.3 Germany
    • 7.3.4 France
    • 7.3.5 U.K.
    • 7.3.6 Italy
    • 7.3.7 Russia

8 Asia Pacific

  • 8.1 Asia Pacific Dermatology OTC Medications Market Size by Type
    • 8.1.1 Asia Pacific Dermatology OTC Medications Sales by Type (2018-2027)
    • 8.1.2 Asia Pacific Dermatology OTC Medications Revenue by Type (2018-2027)
  • 8.2 Asia Pacific Dermatology OTC Medications Market Size by Application
    • 8.2.1 Asia Pacific Dermatology OTC Medications Sales by Application (2018-2027)
    • 8.2.2 Asia Pacific Dermatology OTC Medications Revenue by Application (2018-2027)
  • 8.3 Asia Pacific Dermatology OTC Medications Market Size by Region
    • 8.3.1 Asia Pacific Dermatology OTC Medications Sales by Region (2018-2027)
    • 8.3.2 Asia Pacific Dermatology OTC Medications Revenue by Region (2018-2027)
    • 8.3.3 China
    • 8.3.4 Japan
    • 8.3.5 South Korea
    • 8.3.6 India
    • 8.3.7 Australia
    • 8.3.8 Taiwan
    • 8.3.9 Indonesia
    • 8.3.10 Thailand
    • 8.3.11 Malaysia
    • 8.3.12 Philippines

9 Latin America

  • 9.1 Latin America Dermatology OTC Medications Market Size by Type
    • 9.1.1 Latin America Dermatology OTC Medications Sales by Type (2019-2027)
    • 9.1.2 Latin America Dermatology OTC Medications Revenue by Type (2019-2027)
  • 9.2 Latin America Dermatology OTC Medications Market Size by Application
    • 9.2.1 Latin America Dermatology OTC Medications Sales by Application (2019-2027)
    • 9.2.2 Latin America Dermatology OTC Medications Revenue by Application (2019-2027)
  • 9.3 Latin America Dermatology OTC Medications Market Size by Country
    • 9.3.1 Latin America Dermatology OTC Medications Sales by Country (2019-2027)
    • 9.3.2 Latin America Dermatology OTC Medications Revenue by Country (2019-2027)
    • 9.3.3 Mexico
    • 9.3.4 Brazil
    • 9.3.5 Argentina

6 Middle East and Africa

  • 6.1 Middle East and Africa Dermatology OTC Medications Market Size by Type
    • 6.1.1 Middle East and Africa Dermatology OTC Medications Sales by Type (2016-2027)
    • 6.1.2 Middle East and Africa Dermatology OTC Medications Revenue by Type (2016-2027)
  • 6.2 Middle East and Africa Dermatology OTC Medications Market Size by Application
    • 6.2.1 Middle East and Africa Dermatology OTC Medications Sales by Application (2016-2027)
    • 6.2.2 Middle East and Africa Dermatology OTC Medications Revenue by Application (2016-2027)
  • 6.3 Middle East and Africa Dermatology OTC Medications Market Size by Country
    • 6.3.1 Middle East and Africa Dermatology OTC Medications Sales by Country (2016-2027)
    • 6.3.2 Middle East and Africa Dermatology OTC Medications Revenue by Country (2016-2027)
    • 6.3.3 Turkey
    • 6.3.4 Saudi Arabia
    • 6.3.5 U.A.E

11 Company Profiles

  • 11.1 Bayer
    • 11.1.1 Bayer Corporation Information
    • 11.1.2 Bayer Overview
    • 11.1.3 Bayer Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.1.4 Bayer Dermatology OTC Medications Product Description
    • 11.1.5 Bayer Related Developments
  • 11.2 GSK
    • 11.2.1 GSK Corporation Information
    • 11.2.2 GSK Overview
    • 11.2.3 GSK Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.2.4 GSK Dermatology OTC Medications Product Description
    • 11.2.5 GSK Related Developments
  • 11.3 Teva
    • 11.3.1 Teva Corporation Information
    • 11.3.2 Teva Overview
    • 11.3.3 Teva Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.3.4 Teva Dermatology OTC Medications Product Description
    • 11.3.5 Teva Related Developments
  • 11.4 Johnson & Johnson
    • 11.4.1 Johnson & Johnson Corporation Information
    • 11.4.2 Johnson & Johnson Overview
    • 11.4.3 Johnson & Johnson Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.4.4 Johnson & Johnson Dermatology OTC Medications Product Description
    • 11.4.5 Johnson & Johnson Related Developments
  • 11.5 Novartis
    • 11.5.1 Novartis Corporation Information
    • 11.5.2 Novartis Overview
    • 11.5.3 Novartis Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.5.4 Novartis Dermatology OTC Medications Product Description
    • 11.5.5 Novartis Related Developments
  • 11.6 Mylan
    • 11.6.1 Mylan Corporation Information
    • 11.6.2 Mylan Overview
    • 11.6.3 Mylan Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.6.4 Mylan Dermatology OTC Medications Product Description
    • 11.6.5 Mylan Related Developments
  • 11.7 Sun Pharmaceutical
    • 11.7.1 Sun Pharmaceutical Corporation Information
    • 11.7.2 Sun Pharmaceutical Overview
    • 11.7.3 Sun Pharmaceutical Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.7.4 Sun Pharmaceutical Dermatology OTC Medications Product Description
    • 11.7.5 Sun Pharmaceutical Related Developments
  • 11.8 Aurobindo
    • 11.8.1 Aurobindo Corporation Information
    • 11.8.2 Aurobindo Overview
    • 11.8.3 Aurobindo Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.8.4 Aurobindo Dermatology OTC Medications Product Description
    • 11.8.5 Aurobindo Related Developments
  • 11.9 Galderma
    • 11.9.1 Galderma Corporation Information
    • 11.9.2 Galderma Overview
    • 11.9.3 Galderma Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.9.4 Galderma Dermatology OTC Medications Product Description
    • 11.9.5 Galderma Related Developments
  • 11.10 CR SANJIU
    • 11.10.1 CR SANJIU Corporation Information
    • 11.10.2 CR SANJIU Overview
    • 11.10.3 CR SANJIU Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.10.4 CR SANJIU Dermatology OTC Medications Product Description
    • 11.10.5 CR SANJIU Related Developments
  • 11.1 Bayer
    • 11.1.1 Bayer Corporation Information
    • 11.1.2 Bayer Overview
    • 11.1.3 Bayer Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.1.4 Bayer Dermatology OTC Medications Product Description
    • 11.1.5 Bayer Related Developments
  • 11.12 Lupin
    • 11.12.1 Lupin Corporation Information
    • 11.12.2 Lupin Overview
    • 11.12.3 Lupin Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.12.4 Lupin Product Description
    • 11.12.5 Lupin Related Developments
  • 11.13 Bausch Health
    • 11.13.1 Bausch Health Corporation Information
    • 11.13.2 Bausch Health Overview
    • 11.13.3 Bausch Health Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.13.4 Bausch Health Product Description
    • 11.13.5 Bausch Health Related Developments
  • 11.14 Cipla
    • 11.14.1 Cipla Corporation Information
    • 11.14.2 Cipla Overview
    • 11.14.3 Cipla Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.14.4 Cipla Product Description
    • 11.14.5 Cipla Related Developments
  • 11.15 Qilu Pharmaceutical
    • 11.15.1 Qilu Pharmaceutical Corporation Information
    • 11.15.2 Qilu Pharmaceutical Overview
    • 11.15.3 Qilu Pharmaceutical Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.15.4 Qilu Pharmaceutical Product Description
    • 11.15.5 Qilu Pharmaceutical Related Developments
  • 11.16 Almirall
    • 11.16.1 Almirall Corporation Information
    • 11.16.2 Almirall Overview
    • 11.16.3 Almirall Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.16.4 Almirall Product Description
    • 11.16.5 Almirall Related Developments
  • 11.17 Lingrui
    • 11.17.1 Lingrui Corporation Information
    • 11.17.2 Lingrui Overview
    • 11.17.3 Lingrui Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.17.4 Lingrui Product Description
    • 11.17.5 Lingrui Related Developments

12 Value Chain and Sales Channels Analysis

  • 12.1 Dermatology OTC Medications Value Chain Analysis
  • 12.2 Dermatology OTC Medications Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Dermatology OTC Medications Production Mode & Process
  • 12.4 Dermatology OTC Medications Sales and Marketing
    • 12.4.1 Dermatology OTC Medications Sales Channels
    • 12.4.2 Dermatology OTC Medications Distributors
  • 12.5 Dermatology OTC Medications Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

  • 13.1 Dermatology OTC Medications Industry Trends
  • 13.2 Dermatology OTC Medications Market Drivers
  • 13.3 Dermatology OTC Medications Market Challenges
  • 13.4 Dermatology OTC Medications Market Restraints

14 Key Findings in The Global Dermatology OTC Medications Study

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Author Details

    Dermatology OTC Medications market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Dermatology OTC Medications market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

    Segment by Type
    External Use
    Oral
    The classification of dermatology OTC medications includes external use, oral and the proportion of external use in 2019 is about 93%.

    Segment by Application
    Hospital
    Drug Store
    Other
    Dermatology OTC medications is widely used in hospital, drug store and other field. The most proportion of dermatology OTC medications is drug store, and the proportion in 2019 is 58.2%.

    By Company
    Bayer
    GSK
    Teva
    Johnson & Johnson
    Novartis
    Mylan
    Sun Pharmaceutical
    Aurobindo
    Galderma
    CR SANJIU
    Dr. Reddy's
    Lupin
    Bausch Health
    Cipla
    Qilu Pharmaceutical
    Almirall
    Lingrui

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia

    Buy now